Invokana Lawsuit – Ketoacidosis Linked to Diabetes Drug
Invokana, a medication created to control type 2 diabetes, has been linked to ketoacidosis. Some patients were hospitalized and others have even died from this dangerous condition. Ward Black Law is seeking to help those who were not properly warned of Invokana’s potential risks. If you or a loved one experienced serious health issues after taking this drug, specifically ketoacidosis, we may be able to help.
More About Invokana
According to the CDC, there are currently 29 million people in the United States living with diabetes, and more cases of type 2 diabetes are being diagnosed than ever before. Invokana was created by Johnson & Johnson to treat type 2 diabetes and quickly became a popular treatment option. Categorized as a sodium-glucose cotransporter-2 (SGLT2) inhibitor, the medicine works by eliminating blood sugar from the body through urine. This was a unique and well-received treatment option because it attacked blood sugar before diabetes symptoms arose.
Now, the U.S. Food and Drug Administration (FDA), is warning patients that Ivokana and similar drugs may cause ketoacidosis, a serious condition that may lead to hospitalization or death.
Ketoacidosis occurs when the body produces excess levels of blood acids called ketones. According to the Mayo Clinic, it stems from a lack of sufficient insulin and begins as the body breaks down fat for alternative fuel. During this process, toxic acids (ketones) build up in the bloodstream. Symptoms and warning signs include:
- Excessive thirst
- Shortness of breath
- Abdominal pain
- Weakness or fatigue
Mayo Clinic states that signs and symptoms of diabetic ketoacidosis can develop quickly, sometimes within 24 hours. Current cases of Invokana-related ketoacidosis reported to the FDA required hospitalization and developed about two weeks after the patient began taking Invokana.
In the past, ketoacidosis has primarily been an issue for those with type 1 diabetes, however, drugs like Invokana have changed that. As SGLT2 inhibitors are currently only used in type 2 patients, the FDA is continuing to investigate the issue and says they will determine whether changes are needed in prescribing information. Patients currently seeking lawsuits say they were not properly warned of the risk of ketoacidosis. Had they been properly warned, they might have chosen an alternate treatment option or had their health continually monitored for high ketone levels.
Let Us Review Your Invokana Case
If you were hospitalized for ketoacidosis after taking the drug Invokana, or if you have lost a loved one to this condition, you may be entitled to compensation. The prescription drug attorneys at Ward Black Law can help walk you through the process of filing a claim. Call today for a free and confidential case evaluation: (336) 333-2244 or toll-free at 1-877-256-1214. You may also reach us by online inquiry.